[1] Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC. N Engl J Med. 2019 Nov 21.[2] Gefitinib Alone Versus Gefitinib Plus Chemotherapy for NonSmall-Cell Lung Cancer With Mutated Epidermal Gro.....
- 参考文献 -1.李金高, 陈晓钟, 林少俊,等. 鼻咽癌复发,转移诊断专家共识[J]. 中华放射肿瘤学杂志, 2018, 027(001):7-15.2.Mai H Q, Chen Q Y, Chen D, et al. Toripalimab or placebo plus chemotherapy as first-line treatment in adv.....
[1]Jonathan W Goldman, Mikhail Dvorkin, Yuanbin Chen, et al. Durvalumab,with or without tremelimumab,plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung ca.....